Cite

HARVARD Citation

    Wartman, L. et al. (n.d.). A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Leukemia & lymphoma. 57 (3), pp. 728-730. [Online]. 
  
Back to record